Construction of multi-program responsive vitamin E succinate-chitosan-histidine nanocarrier and its response strategy in tumor therapy.
暂无分享,去创建一个
B. Han | Zhiyang Gu | Jing Chang | Xiaotong Chen | Wenya Li | Litong Wang | Li-qun Guo | Saibo Ma | Lan Guo | Cuiyao Li | Jishang Sun
[1] Cuiyun Yu,et al. Dual gatekeepers-modified mesoporous organic silica nanoparticles for synergistic photothermal-chemotherapy of breast cancer. , 2023, Journal of colloid and interface science.
[2] Chenfeng Xu,et al. Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy. , 2023, Journal of controlled release : official journal of the Controlled Release Society.
[3] Mateusz Kciuk,et al. Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity , 2023, Cells.
[4] Xinglu Jiang,et al. Programmed-stimuli responsive carrier-free multidrug delivery system for highly efficient trimodal combination therapy. , 2023, Journal of colloid and interface science.
[5] B. Tzang,et al. Onion-like doxorubicin-carrying polymeric nanomicelles with tumor acidity-sensitive dePEGylation to expose positively-charged chitosan shell for enhanced cancer chemotherapy. , 2022, International Journal of Biological Macromolecules.
[6] B. Ghaemi,et al. Tumor acidic environment directs nanoparticle impacts on cancer cells. , 2022, Journal of colloid and interface science.
[7] Hongyan Zhu,et al. Synergistic Disruption of Metabolic Homeostasis through Hyperbranched Poly(ethylene glycol) Conjugates as Nanotherapeutics to Constrain Cancer Growth , 2022, Advanced materials.
[8] R. Guo,et al. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer. , 2021, Carbohydrate polymers.
[9] Shuo Liu,et al. O-carboxymethyl chitosan based pH/hypoxia-responsive micelles relieve hypoxia and induce ROS in tumor microenvironment. , 2021, Carbohydrate polymers.
[10] Xu Cheng,et al. Acid-sensitive and L61-crosslinked hyaluronic acid nanogels for overcoming tumor drug-resistance. , 2021, International journal of biological macromolecules.
[11] Yan Peng,et al. Mitochondria-targeted vitamin E succinate delivery for reversal of multidrug resistance. , 2021, Journal of controlled release : official journal of the Controlled Release Society.
[12] Ronnie H. Fang,et al. Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs , 2021, Science Advances.
[13] M. Rondoni,et al. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells , 2021, Cell Biology and Toxicology.
[14] Yu Wang,et al. Recent progress in nanomedicine for enhanced cancer chemotherapy , 2021, Theranostics.
[15] Qingsong Liu,et al. Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy. , 2021, International journal of pharmaceutics.
[16] Lian-Hua Fu,et al. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy , 2021, Advanced materials.
[17] B. Bagheri,et al. Self-assembled heptamethine cyanine dye dimer as a novel theranostic drug delivery carrier for effective image-guided chemo-photothermal cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[18] Y. Assaraf,et al. Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp) , 2020, Medicinal research reviews.
[19] Stephen J. Florczyk,et al. 3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells. , 2020, Biomaterials.
[20] P. Xie,et al. Core-shell-corona chitosan-based micelles for tumor intracellular pH-triggered drug delivery: Improving performance by grafting polycation. , 2019, International journal of biological macromolecules.
[21] C. Adamo,et al. In Silico Investigation of the Aggregation‐Caused Quenching: the “Tolane‐Based Molecule” Case , 2019, ChemPhotoChem.
[22] R. Shiji,et al. Overcoming drug-resistance in lung cancer cells by paclitaxel loaded galactoxyloglucan nanoparticles. , 2019, International journal of biological macromolecules.
[23] Xinyuan Zhu,et al. A new insight into the reversal of multidrug resistance in cancer by nanodrugs. , 2019, Biomaterials science.
[24] Xiaohua Tian,et al. Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier. , 2019, ACS applied materials & interfaces.
[25] Yang Wu,et al. Efficient fabrication of reversible pH-induced carboxymethyl chitosan nanoparticles for antitumor drug delivery under weakly acidic microenvironment. , 2019, International journal of biological macromolecules.
[26] Yangling Guo,et al. Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel. , 2019, Carbohydrate polymers.
[27] Gabriela G Pereira,et al. Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery , 2019, Pharmaceutics.
[28] P. Liu,et al. One-pot fabrication of pH/reduction dual-stimuli responsive chitosan-based supramolecular nanogels for leakage-free tumor-specific DOX delivery with enhanced anti-cancer efficacy. , 2018, Carbohydrate polymers.
[29] Zhenhai Zhang,et al. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma. , 2018, Carbohydrate polymers.
[30] Yu Qin,et al. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy. , 2018, Acta biomaterialia.
[31] Cui Tang,et al. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer. , 2018, Acta biomaterialia.
[32] Jianqing Gao,et al. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer , 2018, Acta Pharmacologica Sinica.
[33] M. Gottesman,et al. Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.
[34] Yunbing Wang,et al. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy. , 2018, Acta biomaterialia.
[35] A. De Angelis,et al. Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib , 2018, Oxidative medicine and cellular longevity.
[36] M. Kurisawa,et al. Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)–Green Tea Catechin Conjugate for Cancer Therapy , 2018, Advanced materials.
[37] Conglian Yang,et al. Recent Advances in the Application of Vitamin E TPGS for Drug Delivery , 2018, Theranostics.
[38] Jufang Wang,et al. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. , 2017, Acta biomaterialia.
[39] Hyun-Jong Cho,et al. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. , 2017, Acta biomaterialia.
[40] Ruslan G. Tuguntaev,et al. P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance. , 2017, ACS applied materials & interfaces.
[41] O. Aharonson,et al. A multiple-impact origin for the Moon , 2017, 1903.02525.
[42] Ben Zhong Tang,et al. Long-Term Real-Time In Vivo Drug Release Monitoring with AIE Thermogelling Polymer. , 2017, Small.
[43] K. Ulbrich,et al. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[44] Y. Assaraf,et al. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[45] Sarah E. Seton-Rogers. Resistance: Following different paths , 2016, Nature Reviews. Cancer.
[46] Yadong Li. Realize molecular surgical knife in tumor therapy by nanotechnology , 2015, Science China Materials.
[47] Kuan-Yi Lee,et al. Vitamin E containing polymer micelles for reducing normal cell cytotoxicity and enhancing chemotherapy efficacy. , 2015, Acta biomaterialia.
[48] P. Chu,et al. Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR. , 2014, Biomaterials.
[49] M. Bentires-Alj,et al. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance , 2014, Oncogene.
[50] Chaoliang He,et al. Intercellular pH-responsive histidine modified dextran-g-cholesterol micelle for anticancer drug delivery. , 2014, Colloids and surfaces. B, Biointerfaces.
[51] Jin-Zhi Du,et al. Doxorubicin Conjugate of Poly(Ethylene Glycol)‐Block‐Polyphosphoester for Cancer Therapy , 2014, Advanced healthcare materials.
[52] J. Ljubimova,et al. Nanomedicine therapeutic approaches to overcome cancer drug resistance. , 2013, Advanced drug delivery reviews.
[53] B. Rigas,et al. Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. , 2012, Nanomedicine.
[54] Qin Chen,et al. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. , 2012, Biomaterials.
[55] Yan Zhao,et al. Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux. , 2011, Cancer letters.
[56] F. Sharom,et al. ABC efflux pump-based resistance to chemotherapy drugs. , 2009, Chemical reviews.
[57] You Han Bae,et al. Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.
[58] H. Kawakami,et al. Design of a poly(L‐histidine)‐carbohydrate conjugate for a new pH‐sensitive drug carrier , 2004 .
[59] Chava Kimchi-Sarfaty,et al. P-glycoprotein: from genomics to mechanism , 2003, Oncogene.
[60] G. Embery,et al. Inhibition of hydroxyapatite crystal growth by bone proteoglycans and proteoglycan components. , 2002, Biochemical and biophysical research communications.
[61] U. Brinkmann,et al. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. , 2001, Pharmacogenomics.
[62] Zhe-Sheng Chen,et al. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[63] B. Chabner,et al. Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.
[64] M. Gottesman,et al. Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.